The company achieved company records for 4Q and annual sales despite October-December daily sales growth that was half of the previous quarter.
Latest In Earnings
Global Industrial's 2024 sales increase was predominantly driven by its 2023 acquisition of Indoff, though decelerating in the back half.
Home Depot reported an improvement in customer demand in 4Q as the company broke a same-store decline in sales which persisted over the past two years.
Resideo Technologies reported strong Q4 and full-year financial growth, driven by a sales increase in its ADI unit and the integration of Snap One.
The company reported a decline in 4Q sales and gross margin, impacted by lower core organic sales and ongoing single-family and multi-family margin normalization, respectively.
Hillman Solutions reported a record 4Q sales growth, while its Canada and Robotics & Digital sales showed a continued sales decline in 2024.
GPC’s 2024 results show overall sales growth driven by acquisitions and favorable currency impacts, while its industrial parts subsidiary, Motion, continues to face sales declines.
The company reported growth in its eCommerce and mobile apps for both the full year and 4Q, with additional initiatives planned for 2025.
DNOW’s earnings show strong U.S. and Canada sales growth, but a decline in international performance, with the company projecting flat-to-modest growth for 2025.
Rexel reported that positive momentum in North America slightly offset the softer conditions in Europe, notably in the company’s electrification segment.
Wesco said it expects organic sales and operating margin to grow in 2025.
In addition to announcing its forthcoming split, Honeywell reported its 2024 financial results, which showed an increase in 4Q sales and organic growth.
Weather was a considerable headwind during January, but daily sales growth increased following a recent lowpoint in December. See our full breakdown of the monthly figures.
Full year net sales dipped slightly, driven by a decrease in organic sales and partially offset by acquisition-related sales.
The company said it expects EBITDA to expand in 2025 as it pursues a return to historical gross margin of about 35%.
The company continued to see organic growth that outpaced market averages, ending the year with strong margin gains.
The company reported two of its three segments showing an increase in revenue, while the departure of Optimum impacted its Pharmaceuticals segment.
Sales declined in the Americas and EMEA year-over-year, but Asia sales increased for the second consecutive quarter.
Applied’s total sales declined year-over-year, but acquisitions drove most of the increase while foreign currency translation negatively impacted sales.
The company reported modest overall 4Q sales and profit growth that outpaced a decline in full-year sales.
